Niklaus Schäfer

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

130 publications

Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: A pilot study.
Durante Steve, Dunet Vincent, Gorostidi Fraçois, Mitsakis Periklis, Schaefer Niklaus, Delage Judith, Prior John O..
Monte Carlo<sup>90</sup>Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation.
Auditore L., Amato E., Boughdad S., Meyer M., Testart N., Cicone F., Beigelman-Aubry C., Prior J., Schaefer N., Gnesin S. Physics in medicine and biology. Peer-reviewed.
Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T., Golfieri R., Pech M., Pfammatter T., Arnold D., Cianni R., Maleux G., Munneke G., Pellerin O., Peynircioglu B. et al. Cardiovascular and interventional radiology. Peer-reviewed.
Husband and Reznek's Imaging in Oncology (4th Edition) ; Chapter PET principles
Schaefer Niklaus, Prior John, Marie Nicod - Lalonde, Jreige Mario, CRC Press; 4 edition.
Outpatient Yttrium-90 microsphere radioembolization: assessment of radiation safety and quantification of post-treatment adverse events causing hospitalization.
Aberle S., Kenkel D., Becker A.S., Puippe G., Burger I., Schaefer N., Pfammatter T., 2020/10. La Radiologia medica, 125 (10) pp. 971-980. Peer-reviewed.
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis.
Kamani C.H., Allenbach G., Jreige M., Pavon A.G., Meyer M., Testart N., Firsova M., Fernandes Vieira V., Boughdad S., Nicod Lalonde M. et al., 2020/09/25. Diagnostics, 10 (10). Peer-reviewed.
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France.
Loffroy R., Ronot M., Greget M., Bouvier A., Mastier C., Sengel C., Tselikas L., Arnold D., Maleux G., Pelage J.P. et al., 2020/09/25. Cardiovascular and interventional radiology. Peer-reviewed.
<sup>177</sup>Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma.
Delage J.A., Faivre-Chauvet A., Fierle J.K., Gnesin S., Schaefer N., Coukos G., Dunn S.M., Viertl D., Prior J.O., 2020/08/17. EJNMMI research, 10 (1) p. 98. Peer-reviewed.
Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium.
Girardet R., Boughdad S., Digklia A., Beigelman C., Meyer M., Schaefer N., Vermersch M., Hocquelet A., Tsoumakidou G., Denys A. et al., 2020/08/05. Cardiovascular and interventional radiology. Peer-reviewed.
Preclinical Evaluation and Dosimetry of [<sup>111</sup>In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1).
Cicone F., Denoël T., Gnesin S., Riggi N., Irving M., Jakka G., Schaefer N., Viertl D., Coukos G., Prior J.O., 2020/08. Molecular imaging and biology, 22 (4) pp. 979-991. Peer-reviewed.
Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability.
Dromain C., Sundin A., Najran P., Vidal Trueba H., Dioguardi Burgio M., Crona J., Opalinska M., Carvalho L., Franca R., Borg P. et al., 2020/07/27. Neuroendocrinology. Peer-reviewed.
Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice.
Maas M., Beets-Tan R., Gaubert J.Y., Gomez Munoz F., Habert P., Klompenhouwer L.G., Vilares Morgado P., Schaefer N., Cornelis F.H., Solomon S.B. et al., 2020/07/16. Insights into imaging, 11 (1) p. 83. Peer-reviewed.
Added value of <sup>18</sup>F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.
Kamani C.H., Jreige M., Pappon M., Fischbacher A., Borens O., Monney P., Nicod Lalonde M., Schaefer N., Prior J.O., 2020/07. European journal of nuclear medicine and molecular imaging, 47 (8) pp. 2036-2037. Peer-reviewed.
Prevalence and clinical significance of incidental 18F-FDG uptake in the pituitary
Signore Giovanni, Meyer Marie, Albano Domenico, Bertagna Francesco, Nicod-Lalonde Marie, Schaefer Niklaus, Giovanella Luca, Prior John O., Treglia Giorgio, 2020/06/25. Clinical and Translational Imaging.
Radiation dosimetry of <sup>18</sup>F-AzaFol: A first in-human use of a folate receptor PET tracer.
Gnesin S., Müller J., Burger I.A., Meisel A., Siano M., Früh M., Choschzick M., Müller C., Schibli R., Ametamey S.M. et al., 2020/04/08. EJNMMI research, 10 (1) p. 32. Peer-reviewed.
From Theranostics to Immunotheranostics: the Concept
Schaefer Niklaus, Prior John O., Schottelius Margret, 2020/04. Nuclear Medicine and Molecular Imaging, 54 (2) pp. 81-85. Peer-reviewed.
First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver.
Ponti A., Denys A., Digklia A., Schaefer N., Hocquelet A., Knebel J.F., Michielin O., Dromain C., Duran R., 2020/03. Journal of nuclear medicine, 61 (3) pp. 350-356. Peer-reviewed.
Variations in radioiodine ablation: decision-making after total thyroidectomy.
Maas O., Forrer F., Maas M., Panje C.M., Blautzik J., Brühlmeier M., Engel-Bicik I., Giovanella L., Haldemann A., Kamel M.E. et al., 2020/03. European journal of nuclear medicine and molecular imaging, 47 (3) pp. 554-560. Peer-reviewed.
Increased <sup>18</sup>F-FDG signal recovery from small physiological structures in digital PET/CT and application to the pituitary gland.
Meyer M., Allenbach G., Nicod Lalonde M., Schaefer N., Prior J.O., Gnesin S., 2020/01/15. Scientific reports, 10 (1) p. 368. Peer-reviewed.
Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and <sup>18</sup>F-FDG PET/CT in Correlation with Clinical Pathologic Outcome.
Jreige M., Dunet V., Letovanec I., Prior J.O., Meuli R.A., Beigelman-Aubry C., Schaefer N., 2020/01. Journal of nuclear medicine, 61 (1) pp. 26-32. Peer-reviewed.
Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F., Jreige M., Schaefer N., Becce F., Prior J.O., Nicod Lalonde M., 2019/12/26. BMC musculoskeletal disorders, 20 (1) p. 619. Peer-reviewed.
Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.
Meyer M., Nicod Lalonde M., Testart N., Jreige M., Kamani C., Boughdad S., Muoio B., Becce F., Schaefer N., Candrian C. et al., 2019/12/18. Diagnostics, 10 (1). Peer-reviewed.
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.
Lamarca A., Ronot M., Moalla S., Crona J., Opalinska M., Lopez Lopez C., Pezzutti D., Najran P., Carvhalo L., Bezerra ROF et al., 2019/11/15. Clinical cancer research, 25 (22) pp. 6692-6699. Peer-reviewed.
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Lamarca A., Crona J., Ronot M., Opalinska M., Lopez Lopez C., Pezzutti D., Najran P., Carvhalo L., Franca Bezerra R.O., Borg P. et al., 2019/11. The oncologist, 24 (11) pp. e1082-e1090. Peer-reviewed.
Nuklearmedizinische Diagnostik und Therapie im Kontext der Modernen Onkologie [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology]
Schaefer N., Prior J., 2019/09. Therapeutische Umschau. Revue therapeutique, 76 (4) pp. 167-172. Peer-reviewed.
<sup>18</sup>F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.
Jreige M., Letovanec I., Chaba K., Renaud S., Rusakiewicz S., Cristina V., Peters S., Krueger T., de Leval L., Kandalaft L.E. et al., 2019/08. European journal of nuclear medicine and molecular imaging, 46 (9) pp. 1859-1868. Peer-reviewed.
Diagnostic Performance of PET or PET/CT Using <sup>18</sup>F-FDG Labeled White Blood Cells in Infectious Diseases: A Systematic Review and a Bivariate Meta-Analysis.
Meyer M., Testart N., Jreige M., Kamani C., Moshebah M., Muoio B., Nicod-Lalonde M., Schaefer N., Giovanella L., Prior J.O. et al., 2019/06/15. Diagnostics, 9 (2). Peer-reviewed.
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice.
Cicone F., Gnesin S., Denoël T., Stora T., van der Meulen N.P., Müller C., Vermeulen C., Benešová M., Köster U., Johnston K. et al., 2019/06/11. EJNMMI research, 9 (1) p. 53. Peer-reviewed.
Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study.
Lengwiler E., Stampf S., Zippelius A., Salati E., Zaman K., Schäfer N., Schardt J., Siano M., Hofbauer G., The Swiss Transplant Cohort Study, 2019/05/06. Swiss medical weekly, 149 pp. w20078. Peer-reviewed.
First experience of durable cytoreduction in chronic lymphoid leukemia with (177)Lu-DOTATATE.
Savovic T., Prior J.O., Nicod-Lalonde M., Bressoud A., Roux S., Schaefer N., Meyer M., 2019/03/27. Medical oncology, 36 (5) p. 41. Peer-reviewed.
Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis.
Haghayegh Jahromi N., Marchetti L., Moalli F., Duc D., Basso C., Tardent H., Kaba E., Deutsch U., Pot C., Sallusto F. et al., 2019. Frontiers in immunology, 10 p. 3056. Peer-reviewed.
Nuclear Medicine Therapy : Side Effects and Complications
Schaefer Niklaus, Giovanella Luca, 2019., Springer International Publishing.
Nuklearmedizin: Von Diagnostik zur Therapie zur Theranostik am Beispiel der Lutetium-177-PSMA-Therapie
Schaefer Niklaus, 2019. Swiss Medical Forum.
Selective Internal Radiotherapy (SIRT) of Primary Hepatic Carcinoma and Liver Metastases
Schaefer Niklaus, 2019. pp. 101-112 dans Nuclear Medicine Therapy, Springer International Publishing.
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.
Degrauwe N., Hocquelet A., Digklia A., Schaefer N., Denys A., Duran R., 2019. Frontiers in pharmacology, 10 p. 450. Peer-reviewed.
Signature of survival: a <sup>18</sup>F-FDG PET based whole-liver radiomic analysis predicts survival after <sup>90</sup>Y-TARE for hepatocellular carcinoma.
Blanc-Durand P., Van Der Gucht A., Jreige M., Nicod-Lalonde M., Silva-Monteiro M., Prior J.O., Denys A., Depeursinge A., Schaefer N., 2018/01/12. Oncotarget, 9 (4) pp. 4549-4558. Peer-reviewed.
Additional value of tumour growth rate (TGR) in patients (pts) diagnosed with well-differentiated neuroendocrine tumours (NETs) achieving RECIST-defined stable disease (SD): Subgroup analysis of the GREPONET study.
Schaefer Niklaus, 2018. journal of clinical oncology.
Analysis of Pulmonary Lymphangitic Carcinomatosis (PLC) in Non-Small Cell Lung Cancer (NSCLC): Applying Radiomics to PET/CT
Analyzing Tumor Necrosis in NSCLC: Radiomics applied to FDG PET/CT Imaging
Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
Blanc-Durand P., Van Der Gucht A., Schaefer N., Itti E., Prior J.O., 2018. PloS one, 13 (4) pp. e0195798. Peer-reviewed.
Automatic Lesion Detection and Segmentation of 18FET PET in gliomas: A Full 3D U-Net Convolutional Neural Network Study.
Schaefer Niklaus, 2018. Journal of Nuclear Medicine.
Gynecologic Cancers
Rezaee Alireza, Schäfer Niklaus, Avril Norbert, Hefler Lukas, Langsteger Werner, Beheshti Mohsen, 2018. pp. 169-198 dans PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging, Elsevier.
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
Hot-to-Global Volume Ratio (HGVR): To predict PD-L1 tumoral expression, its correlation to necrosis and outcome in NSCLC patients treated with checkpoint inhibitors using standard FDG PET/CT
Novel approach for I-123-Ioflupane analysis using xSPECT quantification: Reference values in a normal population
Schaefer Niklaus, 2018. dans Journal of Nuclear Medicine.
Pretreatment 18F-FDG PET whole-liver radiomics analysis predicts toxicity after 90Y-TARE for unresectable hepatocellular carcinoma
Schaefer Niklaus, 2018. dans Journal of Nuclear Medicine.
Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma
Schaefer Niklaus, 2018. Oncotarget.
Standard FDG-PET/CT using perilesional metabolic parameters outperforms HRCT for the detection of lymphangitic carcinomatosis
Schaefer Niklaus, 2018. dans Journal of Nuclear Medicine.
Tc-99m-DPD bone scan quantification: Tibial and Patellar Subchondral Bone Uptake Assessment in Knee Osteoarthritis (OA)
Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma.
Van Der Gucht A., Maged Z., Burruni R., Barras J.L., Schaefer N., 2018/01. Clinical nuclear medicine, 43 (1) pp. 41-43. Peer-reviewed.
Tumor Necrosis in NSCLC revealed by metabolic analysis of FDG PET/CT imaging
Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
Blanc-Durand P., Van Der Gucht A., Verger A., Langen K.J., Dunet V., Bloch J., Brouland J.P., Nicod-Lalonde M., Schaefer N., Prior J.O., 2018. PloS one, 13 (6) pp. e0199379. Peer-reviewed.
xSPECT derived absolute and relative SUV: Efficient tools for I-123-ioflupane analysis
Schaefer Niklaus, 2018. dans Journal of Nuclear Medicine.
Blanc-Durand P, Van Der Gucht A, Kourilsky A, Dunet V, Verger A, Langen K, Jreige M, Nicod-Lalonde M, Schaefer N, Prior JO (eds.), 2017/10., European Journal of Nuclear Medicine and Molecular Imaging, 44 S2 1, Springer Science and Business Media LLC.
Resin Versus Glass Microspheres for (90)Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry.
Van Der Gucht A., Jreige M., Denys A., Blanc-Durand P., Boubaker A., Pomoni A., Mitsakis P., Silva-Monteiro M., Gnesin S., Lalonde M.N. et al., 2017/08. Journal of nuclear medicine, 58 (8) pp. 1334-1340. Peer-reviewed.
(18)F-FDG PET/CT predicts survival after (90)Y transarterial radioembolization in unresectable hepatocellular carcinoma.
Jreige M., Mitsakis P., Van Der Gucht A., Pomoni A., Silva-Monteiro M., Gnesin S., Boubaker A., Nicod-Lalonde M., Duran R., Prior J.O. et al., 2017/07. European journal of nuclear medicine and molecular imaging, 44 (7) pp. 1215-1222. Peer-reviewed.
18F-FDG PET-based Radiomics Score Predicts Survival in Patients treated with Yttrium-90 Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma
Blanc-Durand Paul, Van der Gucht Axel, Jreige Mario, Prior John, Schaefer Niklaus (eds.), 2017., 58 supplement 1 460, Society of Nuclear Medicine.
18F-FDG PET/CT But Not Morphological Parameters Predict Survival after Yttrium-90 Transarterial Radioembolization in Unresectable Hepatocellular Carcinoma: an updated analysis
Jreige Mario, MITSAKIS PERIKLIS, Van Der Gucht Axel, Monteiro Marina, Gnesin Silvano, Nicod-Lalonde Marie, Duran Rafael, Prior John, Schaefer Niklaus (eds.), 2017., 58 supplement 1 534, Society of Nuclear Medicine.
PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging
Beheshti Mohsen, Langsteger Werner, Rezaee Alireza, Buck Andreas, Schaefer Niklaus (eds.)Beheshti Mohsen, Langsteger Werner, Rezaee Alireza, Buck Andreas, Schaefer Niklaus, 2017., 1 édition, Mohsen Beheshti, MD, FASNC, FACE, Werner Langsteger, MD, FACE and Alireza Rezaee, MD, ABNM.
Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
Seystahl K., Stoecklein V., Schüller U., Rushing E., Nicolas G., Schäfer N., Ilhan H., Pangalu A., Weller M., Tonn J.C. et al., 2016/11. Neuro-oncology, 18 (11) pp. 1538-1547. Peer-reviewed.
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Sommerauer M., Burkhardt J.K., Frontzek K., Rushing E., Buck A., Krayenbuehl N., Weller M., Schaefer N., Kuhn F.P., 2016/07. Neuro-oncology, 18 (7) pp. 1021-1027.
Sarcoïdose cardiaque: sept points à rappeler pour ne pas manquer le diagnostic [Cardiac sarcoidosis: seven keypoints to remind in order to avoid misdiagnosis]
Porretta A.P., Van der Gucht A., Bisch L., Mitsakis P., Pomoni A., Allenbach G., Lalonde M.N., Schaefer N., Buss G., Prior J.O. et al., 2016/05/25. Revue medicale suisse, 12 (520) pp. 1035-1036,1038-1041.
Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
Reiner C.S., Gordic S., Puippe G., Morsbach F., Wurnig M., Schaefer N., Veit-Haibach P., Pfammatter T., Alkadhi H., 2016/03. Cardiovascular and interventional radiology, 39 (3) pp. 400-408. Peer-reviewed.
Medikamentöse Behandlung des metastasierten Prostatakarzinoms
Richard Cathomas, Hans-Peter Schmid, Daniel M Aebersold, Marie-Laure Amram, Dominik Berthold, Daniel Eberli, Silke Gillessen, Christophe Iselin, Patrice Jichlinski, Michael Müntener et al., 2016. SWISS MEDICAL FORUM – SCHWEIZERISCHES MEDIZIN-FORUM, 16 (11).
Nuklearmedizinische Verfahren
Kreuzer Karl-Anton, Beyer Jörg, 2016. dans Hämatologie und Onkologie: Fallorientierte Darstellung-rationale Diagnostik und Therapie, Georg Thieme Verlag.
Role of Nuclear Medicine in Diagnosis of Bone Metastasis
Nicod Lalonde Marie, Prior John, Schaefer Niklaus, 2016. InFo Onkologie & Hämatologie, 4 (6).
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
Herrmann K., Queiroz M., Huellner M.W., de Galiza Barbosa F., Buck A., Schaefer N., Stolzman P., Veit-Haibach P., 2015/12/23. BMC cancer, 15 p. 1002. Peer-reviewed.
CME [Diffuse large B-cell lymphoma]
Fuchs I., Petrausch U., Pangalu A., Schäfer N., Samaras P., 2015/04/22. Praxis, 104 (9) pp. 441-449. Peer-reviewed.
Arterial Therapies of Non-Colorectal Liver Metastases.
Puippe G., Pfammatter T., Schaefer N., 2015. Viszeralmedizin, 31 (6) pp. 414-422. Peer-reviewed.
Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.
Sah B.R., Burger I.A., Schibli R., Friebe M., Dinkelborg L., Graham K., Borkowski S., Bacher-Stier C., Valencia R., Srinivasan A. et al., 2015. Journal of Nuclear Medicine, 56 (3) pp. 372-378. Peer-reviewed.
Steinert Hans, Dreier Jil, Dummer Reinhard, Schäfer Niklaus, 2015. dans Molecular Anatomic Imaging, von Schulthess, Gustav K.
Sensitivity and Specificity of Dual-Isotope 99mTc-Tetrofosmin and 123I Sodium Iodide Single Photon Emission Computed Tomography (SPECT) in Hyperparathyroidism.
Sommerauer M., Graf C., Schäfer N., Huber G., Schneider P., Wüthrich R., Schmid C., Steinert H., 2015. PloS one, 10 (6) pp. e0129194. Peer-reviewed.
Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion
Reiner Caecilia S, Morsbach Fabian, Sah Bert-Ram, Puippe Gilbert, Schaefer Niklaus, Pfammatter Thomas, Alkadhi Hatem, 2014. Journal of Vascular and Interventional Radiology, 25 (5) pp. 747-759.
Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
Reiner C.S., Morsbach F., Sah B.R., Puippe G., Schaefer N., Pfammatter T., Alkadhi H., 2014. Journal of Vascular and Interventional Radiology : Jvir, 25 (5) pp. 747-759. Peer-reviewed.
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Burger I.A., Zitzmann-Kolbe S., Pruim J., Friebe M., Graham K., Stephens A., Dinkelborg L., Kowal K., Schibli R., Luurtsema G. et al., 2014. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 55 (11) pp. 1778-1785. Peer-reviewed.
Hida Scan Of The Flr Is Superior To Volumetry To Assess Liver Function In Alpps
Schadde E, Lesurtel M, Schäfer N, Clavien P, 2014. The Official Journal of The International Hepato Pancreato Biliary Association, 16 p. 20.
Lymphoma: Management Using PET/CT
Schaefer Niklaus G, 2014. pp. 257-260 dans Diseases of the Abdomen and Pelvis 2014–2017, Springer.
Patient Selection for Selective Internal Radionuclide Therapy
Schaefer Niklaus, 2014. dans Annual Congress of the European Association of Nuclear Medicine.
Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques.
Morsbach F., Sah B.R., Spring L., Puippe G., Gordic S., Seifert B., Schaefer N., Pfammatter T., Alkadhi H., Reiner C.S., 2014. European Radiology, 24 (7) pp. 1455-1465. Peer-reviewed.
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection.
Reiner C.S., Stolzmann P., Husmann L., Burger I.A., Hüllner M.W., Schaefer N.G., Schneider P.M., von Schulthess G.K., Veit-Haibach P., 2014. European Journal of Nuclear Medicine and Molecular Imaging, 41 (4) pp. 649-658.
Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
Sah B.R., Schibli R., Waibel R., von Boehmer L., Bläuenstein P., Nexo E., Johayem A., Fischer E., Müller E., Soyka J.D. et al., 2014. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 55 (1) pp. 43-49.
Combined PET/CT-perfusion in patients with head and neck cancers
Veit-Haibach Patrick, Schmid Daniel, Strobel Klaus, Soyka Jan D, Schaefer Niklaus G, Haerle Stephan K, Huber Gerhard, Studer Gabriele, Seifert Burkhardt, Hany Thomas F, 2013. European radiology, 23 (1) pp. 163-173.
Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases
Morsbach Fabian, Pfammatter Thomas, Reiner Caecilia S, Fischer Michael A, Sah Bert-Ram, Winklhofer Sebastian, Klotz Ernst, Frauenfelder Thomas, Knuth Alexander, Seifert Burkhardt, 2013. Investigative radiology, 48 (11) pp. 787-794.
In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548
Kähkönen Esa, Jambor Ivan, Kemppainen Jukka, Lehtiö Kaisa, Grönroos Tove J, Kuisma Anna, Luoto Pauliina, Sipilä Henri J, Tolvanen Tuula, Alanen Kalle, 2013. Clinical cancer research, 19 (19) pp. 5434-5443.
NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma
von Boehmer Lotta, Mattle Muriel, Bode Peter, Landshammer Alexandro, Schäfer Carolin, Nuber Natko, Ritter Gerd, Old Lloyd, Moch Holger, Schäfer Niklaus, 2013. Cancer Immunity Archive, 13 (3) p. 12.
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation
Samaras Panagiotis, Zardavas Dimitrios, Petrausch Ulf, Buset Elefteri M, Haile Sarah R, Honegger Hanspeter, Siciliano Raffaele Daniele, Schanz Urs, Mischo Axel, Schäfer Niklaus G, 2013. Swiss Med Wkly, 143 pp. w13791.
Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient
Pfrommer Sarah, Weber Achim, Dutkowski Philipp, Schäfer Niklaus G, Müllhaupt Beat, Bourquin Jean-Pierre, Breitenstein Stefan, Pestalozzi Bernhard C, Stenner Frank, Renner Christoph, 2013. Case reports in oncology, 6 (3) pp. 497-503.
Clinical impact of 18 F-choline PET/CT in patients with recurrent prostate cancer
Schaefer Niklaus, 2012. European journal of nuclear medicine and molecular imaging.
Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT
Schaefer Niklaus G, Veit-Haibach Patrick, Soyka Jan D, Steinert Hans C, Stahel Rolf A, 2012. European journal of radiology, 81 (1) pp. e19-e25.
Die Nachsorge beim Hodgkin-Lymphom/Antworten
Petrausch U, Samaras P, Mischo A, Stenner F, Tinguely M, Schäfer N, Studer G, Renner C, 2012. Praxis-Bern, 101 (1) p. 63.
Immunosuppression and lung cancer of donor origin after bilateral lung transplantation
von Boehmer Lotta, Draenert Alice, Jungraithmayr Wolfgang, Inci Ilhan, Niklaus Schäfer, Boehler Annette, Hofer Markus, Stahel Rolf, Soltermann Alex, van den Broek Maries, 2012. Lung Cancer, 76 (1) pp. 118-122.
Impact on management of Gallium-68 DOTATATE PET/CT in patients with neuroendocrine tumors
Assiri Yasser, Schadde Erik, Schibli Roger, Schiesser Marc, Aeschbach Daniela, Trinckauf Josephine, Schaefer Niklaus, 2012. Journal of Nuclear Medicine, 53 (supplement 1) pp. 99-99.
Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion
Reiner Caecilia S, Goetti Robert, Burger Irene A, Fischer Michael A, Frauenfelder Thomas, Knuth Alexander, Pfammatter Thomas, Schaefer Niklaus, Alkadhi Hatem, 2012. Academic Radiology, 19 (5) pp. 613-621.
Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
Schaefer N.G., Geschwind J.F., Engles J., Buchanan J.W., Wahl R.L., 2012/01. Translational research, 159 (1) pp. 51-57. Peer-reviewed.
After care in Hodgkin lymphoma
Petrausch U, Samaras P, Mischo A, Stenner F, Tinguely M, Schäfer N, Studer G, Renner C, 2011. Praxis, 100 (25) pp. 1515-20; quiz 1521-2.
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
Veit-Haibach Patrick, Schiesser Marc, Soyka Jan, Strobel Klaus, Schaefer Niklaus G, Hesselmann Rolf, Clavien P-A, Hany Thomas F, 2011. European radiology, 21 (2) pp. 256-264.
Comparing FDG quantification in tumors with the retention fraction and SUV in a dual scan examination after 60 and 90 minutes
Burger Irene, Huser Dominic, Schaefer Niklaus, Trinckauf Josephine, Burger Cyrill, Buck Alfred, 2011. Journal of Nuclear Medicine, 52 (supplement 1) pp. 2095-2095.
Comparison of BAY 86-4367, a new F-18 labeled bombesin analog, with F-18-ethyl-choline in recurrent and primary prostate cancer patients
Schaefer Niklaus, Valencia Ray, Borkowski Sandra, Geissler Eva, Kristiansen Glen, Rohde Beate, Bacher-Stier Claudia, Krause Bernd Joachim, Hany Thomas, 2011. Journal of Nuclear Medicine, 52 (supplement 1) pp. 40-40.
Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine
Burger Irene A, Husmann Lars, Hany Thomas F, Schmid Daniel T, Schaefer Niklaus G, 2011. Clinical nuclear medicine, 36 (10) pp. 848-853.
Poly (ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma
Schaefer Niklaus G, James Engles, Wahl Richard L, 2011. Nuclear medicine communications, 32 (11) p. 1046.
Radioimmunotherapy in non-Hodgkin lymphoma: opinions of nuclear medicine physicians and radiation oncologists
Schaefer Niklaus G, Huang Peng, Buchanan Julia W, Wahl Richard L, 2011. Journal of Nuclear Medicine, 52 (5) pp. 830-838.
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis
Mischo Axel, Bubel Nina, Cebon Jonathan S, Samaras Panagiotis, Petrausch Ulf, Stenner-Liewen Frank, Schaefer Niklaus G, Kubuschok Boris, Renner Christoph, Wadle Andreas, 2011. International journal of oncology, 39 (1) pp. 287-294.
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Veit-Haibach P., Treyer V., Strobel K., Soyka J.D., Husmann L., Schaefer N.G., Tschopp A., Hany T.F., 2010/10. Abdominal imaging, 35 (5) pp. 528-536. Peer-reviewed.
Radioimmunotherapy in non-Hodgkin lymphoma: opinions of U.S. medical oncologists and hematologists.
Schaefer N.G., Ma J., Huang P., Buchanan J., Wahl R.L., 2010/06. Journal of nuclear medicine, 51 (6) pp. 987-994. Peer-reviewed.
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?
Petrausch U., Samaras P., Veit-Haibach P., Tschopp A., Soyka J.D., Knuth A., Hany T.F., Mischo A., Renner C., Schaefer N.G., 2010/05. Annals of oncology, 21 (5) pp. 1053-1057. Peer-reviewed.
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schaefer Niklaus, 2010/05. The Laryngoscope.
Clinical impact of 18F-Choline PET/CT in patients with recurrent prostate carcinoma
Soyka Jan, Muster Marco, Schick Ulrike, Miralbell Raymond, Jorcano Sandra, Veit-Haibach Patrick, Strobel Klaus, Schaefer Niklaus, Schmid Daniel, Hany Thomas, 2010. Journal of Nuclear Medicine, 51 (supplement 2) pp. 454-454.
Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma
Veit-Haibach Patrick, Schaefer Niklaus G, Steinert Hans C, Soyka Jan D, Seifert Burkhardt, Stahel Rolf A, 2010. Lung Cancer, 67 (3) pp. 311-317.
Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP
Samaras Panagiotis, Heider Helen, Haile Sarah R, Petrausch Ulf, Schaefer Niklaus G, Siciliano Raffaele Daniele, Meisel Alexander, Mischo Axel, Zweifel Martin, Knuth Alexander, 2010. Annals of hematology, 89 (8) pp. 783-787.
Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine
Soyka Jan D, Strobel Klaus, Veit-Haibach Patrick, Schaefer Niklaus G, Schmid Daniel T, Tschopp Alois, Hany Thomas F, 2010. Journal of Nuclear Medicine, 51 (4) pp. 507-510.
PARP inhibitors in combination with external beam and radioimmunotherapy in aggressive lymphoma
Schaefer Niklaus, Engles James, Wahl Richard, 2010. Journal of Nuclear Medicine, 51 (supplement 2) pp. 1135-1135.
Pharmacokinetic of a new Tc-99m labeled vitamin B12 derivative with abolished binding to TC: A story of mice and man
Schibli Roger, Waibel Robert, Schaefer Niklaus, Burger Irene, Blaeuenstein Peter, Johayem Anass, Fischer Eliane, Nexø Ebba, 2010. Journal of Nuclear Medicine, 51 (supplement 2) pp. 485-485.
Pilot study of a new Tc-99m labeled vitamin B12 derivative for detection of cancer
Schaefer Niklaus, Burger Irene, Blaeuenstein Peter, Johayem Anass, Schibli Roger, Schubiger August, 2010. Journal of Nuclear Medicine, 51 (supplement 2) pp. 1252-1252.
Radioimmunotherapy in non-Hodgkin lymphoma: opinions of US medical oncologists and hematologists
Schaefer Niklaus G, Ma Jiemin, Huang Peng, Buchanan Judy, Wahl Richard L, 2010. Journal of Nuclear Medicine, 51 (6) pp. 987-994.
Risk-adapted FDG–PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Petrausch U, Samaras P, Haile SR, Veit-Haibach P, Soyka JD, Knuth A, Hany TF, Mischo A, Renner C, Schäefer NG, 2010. Annals of Oncology, 21 (8) pp. 1694-1698.
The value of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas
Schrepfer Thomas, Haerle Stephan K, Strobel Klaus, Schaefer Niklaus, Hälg Roger A, Huber Gerhard F, 2010. The Laryngoscope, 120 (5) pp. 937-944.
Use of radioimmunotherapy in the United States of America: Opinions of nuclear physicians and radiation oncologists
Schaefer Niklaus, Engles James, Wahl Richard, 2010. Journal of Nuclear Medicine, 51 (supplement 2) pp. 595-595.
Enhancing anti-CD20 directed radioimmunotherapy. Preliminary studies using lenalidomide-accelerated internalization
Schaefer NG, Balasubramanian R, Song H, Engles J, Wahl R, 2009. Journal of Nuclear Medicine, 50 (supplement 2) pp. 1609-1609.
Positron Emission Tomography: Principles and Clinical Applications
Schaefer Niklaus, 2009. dans Husband and Reznek's Imaging in Oncology, Taylor and Francis Ltd.
Gastrointestinal Stromal Tumors
Schaefer Niklaus G., Goerres Gerhard W., 2008. pp. 385-389 dans Cancer Imaging, Elsevier.
New derivatives of vitamin B12 show preferential targeting of tumors
Waibel Robert, Treichler Hansjörg, Schaefer Niklaus G, van Staveren Dave R, Mundwiler Stefan, Kunze Susanne, Küenzi Martin, Alberto Roger, Nüesch Jakob, Knuth Alexander, 2008. Cancer research, 68 (8) pp. 2904-2911.
Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
Schaefer N.G., Strobel K., Taverna C., Hany T.F., 2007/01. European journal of nuclear medicine and molecular imaging, 34 (1) pp. 60-67. Peer-reviewed.
Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18] fluoro-2-deoxy-D-glucose–positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?
Strobel K, Schaefer NG, Renner C, Veit-Haibach P, Husarik D, Koma AY, Hany TF, 2007. Annals of Oncology, 18 (4) pp. 658-664.
Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy—is biopsy of FDG-avid lesions still needed?
Schaefer Niklaus G, Taverna Christian, Strobel Klaus, Wastl Cathrin, Kurrer Michael, Hany Thomas F, 2007. Radiology, 244 (1) pp. 257-262.
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients
Walton S. M., Gerlinger M., de la Rosa O., Nuber N., Knights A., Gati A., Laumer M., Strauss L., Exner C., Schafer N. et al., 2006/12. Journal of Immunology, 177 (11) pp. 8212-8.
Changing PET/CT manifestation of neurolymphomatosis.
Strobel K., Pestalozzi B., Ciernik I., Schaefer N.G., Koma A.Y., Hany T.F., 2006/10. European journal of nuclear medicine and molecular imaging, 33 (10) p. 1244. Peer-reviewed.
Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Strobel K., Schaefer N.G., Husarik D.B., Hany T.F., Steinert H., 2006/10. Clinical nuclear medicine, 31 (10) pp. 624-626. Peer-reviewed.
Potential use of humanized antibodies in the treatment of breast cancer.
Schaefer N.G., Pestalozzi B.C., Knuth A., Renner C., 2006/07. Expert review of anticancer therapy, 6 (7) pp. 1065-1074. Peer-reviewed.
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
Schaefer N.G., Hany T.F., Taverna C., Seifert B., Stumpe K.D., von Schulthess G.K., Goerres G.W., 2004/09. Radiology, 232 (3) pp. 823-829. Peer-reviewed.
PET with 18fluorodeoxyglucose and hexamethylpropylene amine oxime SPECT in late whiplash syndrome.
Bicik I., Radanov B.P., Schäfer N., Dvorak J., Blum B., Weber B., Burger C., von Schulthess G.K., Buck A., 1998/08. Neurology, 51 (2) pp. 345-350. Peer-reviewed.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University